LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 35 of 87
Next
>>
>
851 to 875 of 2160 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Omipalisib	0.37	uM	LJP6	2	N04	72	hr	1657	1271	5505	0.2309	-0.1005
BT-20	Omipalisib	0.37	uM	LJP6	3	N04	72	hr	1657	1377	5505	0.2501	-0.0730
BT-20	GSK 690693	0.37	uM	LJP5	1	F22	72	hr	1657	4524	5505	0.8217	0.7449
BT-20	GSK 690693	0.37	uM	LJP5	2	F22	72	hr	1657	4215	5505	0.7656	0.6646
BT-20	GSK 690693	0.37	uM	LJP5	3	F22	72	hr	1657	4161	5505	0.7558	0.6506
BT-20	GW843682X	0.37	uM	LJP6	1	B16	72	hr	1657	2066	5505	0.3753	0.1061
BT-20	GW843682X	0.37	uM	LJP6	2	B16	72	hr	1657	1995	5505	0.3624	0.0876
BT-20	GW843682X	0.37	uM	LJP6	3	B16	72	hr	1657	2451	5505	0.4452	0.2062
BT-20	HG-5-113-01	0.37	uM	LJP5	1	B10	72	hr	1657	4491	5505	0.8157	0.7363
BT-20	HG-5-113-01	0.37	uM	LJP5	2	B10	72	hr	1657	3763	5505	0.6835	0.5471
BT-20	HG-5-113-01	0.37	uM	LJP5	3	B10	72	hr	1657	4917	5505	0.8931	0.8470
BT-20	HG-5-88-01	0.37	uM	LJP6	1	A22	72	hr	1657	5395	5505	0.9799	0.9712
BT-20	HG-5-88-01	0.37	uM	LJP6	2	A22	72	hr	1657	5074	5505	0.9216	0.8878
BT-20	HG-5-88-01	0.37	uM	LJP6	3	A22	72	hr	1657	5411	5505	0.9828	0.9754
BT-20	Imatinib	0.37	uM	LJP6	1	N16	72	hr	1657	5263	5505	0.9559	0.9369
BT-20	Imatinib	0.37	uM	LJP6	2	N16	72	hr	1657	5572	5505	1.0120	1.0172
BT-20	Imatinib	0.37	uM	LJP6	3	N16	72	hr	1657	5540	5505	1.0062	1.0089
BT-20	JNK-9L	0.37	uM	LJP6	1	K22	72	hr	1657	3253	5505	0.5909	0.4146
BT-20	JNK-9L	0.37	uM	LJP6	2	K22	72	hr	1657	3225	5505	0.5858	0.4073
BT-20	JNK-9L	0.37	uM	LJP6	3	K22	72	hr	1657	3101	5505	0.5632	0.3751
BT-20	JW-7-24-1	0.37	uM	LJP6	1	B22	72	hr	1657	4358	5505	0.7916	0.7017
BT-20	JW-7-24-1	0.37	uM	LJP6	2	B22	72	hr	1657	4711	5505	0.8557	0.7935
BT-20	JW-7-24-1	0.37	uM	LJP6	3	B22	72	hr	1657	4813	5505	0.8742	0.8200
BT-20	Lapatinib	0.37	uM	LJP6	1	M22	72	hr	1657	5323	5505	0.9668	0.9525
BT-20	Lapatinib	0.37	uM	LJP6	2	M22	72	hr	1657	5528	5505	1.0041	1.0058

|<
<<
Previous
Page 35 of 87
Next
>>
>
851 to 875 of 2160 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)